Literature DB >> 17880501

Photodynamic therapy treatment of early oral and laryngeal cancers.

Merrill A Biel1.   

Abstract

Photodynamic therapy (PDT) is a nonsurgical, minimally invasive treatment that uses a light source to activate light-sensitive drugs or photosensitizers in the treatment of cancer and other diseases. PDT has been successfully employed to treat early carcinomas of the oral cavity and larynx preserving normal tissue and vital functions of speech and swallowing. Two hundred seventy-six patients with early carcinomas of the oral cavity and larynx were treated from 1990 to 2006. Cure rates with a single treatment for early laryngeal and oral cancers were 91% and 94%, respectively. PDT is an effective primary and alternative treatment modality for early oral cavity and laryngeal cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880501     DOI: 10.1111/j.1751-1097.2007.00153.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  36 in total

1.  Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.

Authors:  D Separovic; J Bielawski; J S Pierce; S Merchant; A L Tarca; G Bhatti; B Ogretmen; M Korbelik
Journal:  Int J Oncol       Date:  2010-12-06       Impact factor: 5.650

2.  Intraoperative optical assessment of photodynamic therapy response of superficial oral squamous cell carcinoma.

Authors:  Daniel J Rohrbach; Nestor Rigual; Hassan Arshad; Erin C Tracy; Michelle T Cooper; Gal Shafirstein; Gregory Wilding; Mihai Merzianu; Heinz Baumann; Barbara W Henderson; Ulas Sunar
Journal:  J Biomed Opt       Date:  2016-01       Impact factor: 3.170

Review 3.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.

Authors:  Harry Quon; Craig E Grossman; Jarod C Finlay; Timothy C Zhu; Clarice S Clemmens; Kelly M Malloy; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2011-06       Impact factor: 3.631

4.  New Monte Carlo model of cylindrical diffusing fibers illustrates axially heterogeneous fluorescence detection: simulation and experimental validation.

Authors:  Timothy M Baran; Thomas H Foster
Journal:  J Biomed Opt       Date:  2011-08       Impact factor: 3.170

5.  Image-guided Interstitial Photodynamic Therapy for Squamous Cell Carcinomas: Preclinical investigation.

Authors:  Mirabelle Sajisevi; Nestor R Rigual; David A Bellnier; Mukund Seshadri
Journal:  J Oral Maxillofac Surg Med Pathol       Date:  2015-03

Review 6.  Biomodulatory approaches to photodynamic therapy for solid tumors.

Authors:  Sanjay Anand; Bernhard J Ortel; Stephen P Pereira; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

7.  A cell-targeted photodynamic nanomedicine strategy for head and neck cancers.

Authors:  Alyssa Master; Anthony Malamas; Rachna Solanki; Dana M Clausen; Julie L Eiseman; Anirban Sen Gupta
Journal:  Mol Pharm       Date:  2013-04-24       Impact factor: 4.939

8.  Tumour thickness in oral cancer using an intra-oral ultrasound probe.

Authors:  Wouter L Lodder; Hendrik J Teertstra; Ing B Tan; Frank A Pameijer; Ludi E Smeele; Marie-Louise F van Velthuysen; Michiel W M van den Brekel
Journal:  Eur Radiol       Date:  2010-08-03       Impact factor: 5.315

9.  Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapy.

Authors:  Peter H Ahn; Jarod C Finlay; Shannon M Gallagher-Colombo; Harry Quon; Bert W O'Malley; Gregory S Weinstein; Ara Chalian; Kelly Malloy; Thomas Sollecito; Martin Greenberg; Charles B Simone; Sally McNulty; Alexander Lin; Timothy C Zhu; Virginia Livolsi; Michael Feldman; Rosemarie Mick; Keith A Cengel; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-11-04       Impact factor: 3.631

10.  In vitro photodynamic therapy with chlorin e6 leads to apoptosis of human vascular smooth muscle cells.

Authors:  Magdalena Wawrzyńska; Wojciech Kałas; Dariusz Biały; Ewa Zioło; Jacek Arkowski; Walentyna Mazurek; Leon Strzadała
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-02       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.